Lung inflammation biomarkers and lung function in children chronically exposed to arsenic

Toxicology and Applied Pharmacology

Volumn 287, Issue 2, 2015, Pages 161-167

  Olivas Calderón, Edgar ^a,b   Recio Vega, Rogelio ^a   Gandolfi, A Jay ^c,d   Lantz, R Clark ^c,d   González Cortes, Tania ^a   Gonzalez De Alba, Cesar ^a   Froines, John R ^e   Espinosa Fematt, Jorge A ^b  

^a University of Coahuila   (Mexico)

^b UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arsenic; Lung inflammation; Metalloproteinase 9 (MMP 9); Soluble receptor for advanced glycation end products (sRAGE); Sputum; Tissue inhibitor of metalloproteinase (TIMP 1)

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ARSENIC; CACODYLIC ACID; GELATINASE B; TAP WATER; TISSUE INHIBITOR OF METALLOPROTEINASE 1; BIOLOGICAL MARKER; DRINKING WATER; IMMUNOGLOBULIN RECEPTOR; METHANEARSONIC ACID; ORGANOARSENIC DERIVATIVE; WATER POLLUTANT;

ARTICLE; ASSOCIATION; CHILD; CHRONIC COUGH; COOKING; CROSS-SECTIONAL STUDY; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; METHYLATION; NORMAL HUMAN; PNEUMONIA; SPIROMETRY; SPUTUM LEVEL; URINE LEVEL; ADVERSE EFFECTS; ANALYSIS; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMICALLY INDUCED; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY; RURAL POPULATION; URINE; WATER POLLUTANT;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ARSENIC; ARSENICALS; BIOMARKERS; CACODYLIC ACID; CHILD; CROSS-SECTIONAL STUDIES; DRINKING WATER; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 9; PNEUMONIA; RECEPTORS, IMMUNOLOGIC; RURAL POPULATION; SPIROMETRY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; WATER POLLUTANTS;

EID: 84938993207     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2015.06.001     Document Type: Article

References (51)

1. Achanzar, Brambila E.M., Diwan B.A., Webber M.M., Waalkes M.P. Inorganic arsenite-induced malignant transformation of human prostate epithelial cells. J. Natl. Cancer Inst. 2002, 94:1888-1891.
2. American Thoracic Society Standardization of spirometry. Update. Am. J. Respir. Crit. Care Med. 1995, 152:1107-1136.
3. Barker, Godfrey K.M., Fall C., Osmond C., Winter P.D., Shaheen S.O., et al. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 1991, 303:671-675.
4. 74As labeled arsenite. Toxicology 1981, 20:35-44.
5. Bierhaus, Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., et al. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 2005, 83:876-886.
6. Burgess, Kurzius-Spencer M., Poplin G., Littau S., Kopplin M., Sturup S., Boitano S., Lantz R.C., et al. Environmental arsenic exposure, selenium and sputum alpha-1 antitrypsin. J. Exposure Sci. Environ. Epidemiol. 2013, 1-6.
7. CDC Environmental Health, Laboratory Procedure Manual 2004.
8. Chan, Noble-Jamieson C.M., Elliman A., Bryan E.M., Silverman M., et al. Lung function in children of low birth weight. Arch. Dis. Child. 1989, 64:1284-1293.
9. Chiou, Hsueh Y.M., Liaw K.F., Horng S.F., Chiang M.H., Pu Y.S., et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 1995, 55:1296-1300.
10. Concha, Vogler G., Nermell B., Vahter M., et al. Low-level arsenic excretion in breast milk of native Andean women exposed to high levels of arsenic in the drinking water. Int. Arch. Occup. Environ. Health 1998, 71:42-46.
11. Cooper, Myers T.A., Rosenberg M., Chavez M., Hudson L.G., et al. Roles of mitogen activated protein kinases and EGF receptor in arsenite-stimulated matrix metalloproteinase-9 production. Toxicol. Appl. Pharmacol. 2004, 200:177-185.
12. Dauphine, Ferreccio C., Guntur S., Yuan Y., Hammond S.K., Balmes J., Smith A.H., Steinmaus C., et al. Lung function in adults following in utero and childhood exposure to arsenic in drinking water: preliminary findings. Int. Arch. Occup. Environ. Health 2011, 84:591-600.
13. De, Majumdar D., Sen S., Guru S., Kundu S., et al. Pulmonary involvement in chronic arsenic poisoning from drinking contaminated ground-water. J. Assoc. Physicians India 2004, 52:395-400.
14. Okada, Gonoji Y., Naka K., Tomita K., Nakanishi I., Iwata K., Yamashita K., Hayakawa T., et al. Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells: purification and activation of the precursor and enzymic properties. J. Biol. Chem. 1992, 25:21712-21719.
15. Finlay, O'Driscoll L.R., Russell K.J., D'Arcy E.M., Masterson J.B., Fitzgerald M.X., O'Connor C.M., et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am. J. Respir. Crit. Care Med. 1997, 156:240-247.
16. Gopal, Reynaert N., Scheijen J., Schalkwijk C., Franssen F., Wouters E., Rutten E., et al. Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD. Respir. Res. 2014, 15:24.
17. Falcone, Emanuele E., D'Angelo A., Buzzi M.P., Belvito C., Cuccia, et al. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1032-1037.
18. Ferris Epidemiology standardization project: III. Recommended standardized procedures for pulmonary function testing. Am. Rev. Respir. Dis. 1978, 118:55-88.
19. Fry, Navasumrit P., Valiathan C., Svensson J.P., Hogan B.J., Luo M., Bhattacharya S., Kandjanapa K., Soontararuks S., Nookabkaew S., Mahidol C., Ruchirawat M., Samson L.D., et al. Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers. PLoS Genet. 2007, 11:207.
20. Gerhardsson, Brune D., Nordberg G.F., Wester P.O., et al. Multielemental assay of tissues of deceased smelter workers and controls. Sci. Total Environ. 1988, 74:97-110.
21. Hankinson, Odencrantz J.R., Fedan K.B., et al. Spirometric reference values from a sample of the general U.S. population. Am. J. Respir. Crit. Care Med. 1999, 159:179-187.
22. Heindel Role of exposure to environmental chemicals in the developmental basis of disease and dysfunction. Reprod. Toxicol. 2007, 23:257-259.
23. Hofmann, Hansen G., Burdach S., Bartling B., Silber R.E., Simm A., et al. Discrimination of human lung neoplasm from normal lung by two target genes. Am. J. Respir. Crit. Care Med. 2004, 170:516-519.
24. Hopenhayn-Rich, Biggs M.L., Smith A.H., et al. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int. J. Epidemiol. 1998, 27:561-569.
25. Josyula, Poplin G.S., Kurzius-Spencer M., McClellen H.E., Kopplin M.J., Sturup S., Lantz R.C., Burgess J.L., et al. Environmental arsenic exposure and sputum metalloproteinase concentrations. Environ. Res. 2006, 102:283-290.
26. Kumano-Kuramochi M., Ohnishi-Kameyama M., Xie Q., Niimi S., Kubota F., Komba S., Machida S. Minimum stable structure of the receptor for advanced glycation end product possesses multi ligand binding ability. Biochem. Biophys. Res. Commun. 2009, 386:130-134.
27. Lantz, Hays Drug Metab. Rev. 2006, 38(4):791-804.
28. Lantz R.C., Lynch B.J., Boitano S., Poplin G.S., Littau S., Tsaprailis G., Burgess J.L. Pulmonary biomarkers based on alterations in protein expression after exposure to arsenic. Environ. Health Perspect. 2007, 115:586-591.
29. Li, Schmidt Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J. Biol. Chem. 1997, 272:16498-16506.
30. Liang, Li P., Zhao J.X., Dai M.K., Huang K.F., et al. Arsenic trioxide regulates the production and activities of matrix metalloproteinases-1, 2, and 9 in fibroblasts and THP-1. Chin. Med. J. 2012, 125(24):4481-4487.
31. Marafante, Rade J., Sabbioni E., Bertolero F., Foa V., et al. Intracellular interaction and metabolic fate of arsenite in the rabbit. Clin. Toxicol. 1981, 18:1335-1341.
32. Mazumder, Haque R., Ghosh N., De B.K., Santra A., Chakraborti D., et al. Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. Int. J. Epidemiol. 2000, 29:1047-1052.
33. Mazumder, Steinmus C., Bhattacharaya P., von Ehrenstein O.S., Ghosh N., Gotway M., et al. Bronchitis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology 2005, 16:760-765.
34. McCall, Acheson Respiratory disease in infancy. J. Chron. Dis. 1968, 21:349-359.
35. Murphy, Willenbrock Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol. 1995, 248:496-510.
36. Neeper, Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., Elliston K., Stern D., Shaw A., et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 1992, 267:14998-15004.
37. Nemery Metal toxicity and the respiratory tract. Eur. Respir. J. 1990, 3:202-219.
38. NRC (National Research Council) Arsenic in Drinking Water Update 2001, National Academy Press, Washington, USA.
39. Ohnishi, Takagi M., Kurokawa Y., Satomi S., Konttinen Y.T., et al. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab. Invest. 1998, 78:1077-1087.
40. Olsen, Liquori A.E., Zong Y., Lantz R.C., Burgess J.L., Boitano S., et al. Arsenic upregulates MMP-9 and inhibits wound repair in human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 295:263-302.
41. Queisser, Kouri F.M., Königshoff M., Wygrecka M., Schubert U., Eickelberg O., Preissner K.T., et al. Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types. Am. J. Respir. Cell Mol. Biol. 2008, 39(3):337-345.
42. Ramsey, Bosco A., McKenna K., Carter K., Elliot J., Berry L., Sly P., Larcombe A., Zosky G., et al. In utero exposure to arsenic alters lung development and genes related to immune and mucociliary function in mice. Environ. Health Perspect. 2013, 121:244-250.
43. Razo Del, Garcia-Vargas G.G., Vargas H., Albores A., Gonsebatt M.E., et al. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch. Toxicol. 1997, 71:211-217.
44. Recio-Vega, Gonzalez-Cortes T., Olivas-Calderon E., Lantz R.C., Gandolfi A.J., Gonzalez-De Alba C., et al. In utero and early childhood exposure to arsenic decreases lung function in children. J. Appl. Toxicol. 2014, 10.1002/JAT.3023.
45. Saady, Blanke R.V., Poklis A., et al. Estimation of the body burden of arsenic in a child fatally poisoned by arsenite weedkiller. J. Anal. Toxicol. 1989, 13:310-312.
46. Smith, Marshall G., Yuan Y., Ferreccio C., Liaw J., et al. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ. Health Perspect. 2006, 114:1293-1296.
47. Tanaka, Miyazaki N., Oashi K., Tanaka S., Ohmichi M., Abe S., et al. Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma. J. Allergy Clin. Immunol. 2000, 105:900-905.
48. Tohgi, Utsugisawa K., Nagane Y., Yoshimurs M., Ukitsu M., Genda Y., et al. Decrease with age in methylcytosines in the promoter region of receptor for advanced glycated end products (RAGE) gene in autopsy human cortex. Brain Res. Mol. Brain Res. 1999, 65:124-128.
49. Vahter Late effects of early exposure to arsenic. Basic Clin. Pharmacol. Toxicol. 2008, 102:204-211.
50. Vignola, Paganin F., Capieu L., Scichilone N., Bellia M., Maakel L., Bellia V., Godard P., Bousquet J., Chanez P., et al. Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur. Respir. J. 2004, 24:910-917.
51. von Ehrenstein, Mazumder D.N., Yuan Y., Samanta S., Balmes J., Sil A., et al. Decrements in lung function related to arsenic in drinking water in West Bengal, India. Am. J. Epidemiol. 2005, 162:533-541.